Musk, a senior adviser in Trump's White House, targeted the long-running CBS News broadcast in an X post on Feb. 16 ...

The Federal Communications Commission (FCC) released the uncut version of the CBS "60 minutes" interview with the former US vice president Kamala Harris on Wednesday (Feb 5). The FCC demanded the ...

To the editor: The most disturbing news I’ve read is the probable deal to settle President Trump’s baseless lawsuit against CBS for editing choices made for the “60 Minutes” October 2024 ...

Last fall, “60 Minutes,” the highest-rated newsmagazine in America, sought to interview both Trump and Harris for a special pre-election program. Harris agreed and Trump declined ...

60 Minutes' Publicly Releases Transcripts of Interview at Heart of Its Dispute With Trump NEW YORK (AP) — CBS' “60 Minutes” posted online Wednesday the unedited transcripts of its October ...

FCC Releases '60 Minutes' Transcript, Full Video of Kamala Harris Interview By David Shepardson and Dawn Chmielewski WASHINGTON (Reuters) -The Federal Communications Commission said on Wednesday ...

WASHINGTON, Jan. 28, 2025 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals ... sanctioned Phase II clinical study. The study (NCT06656351) will evaluate the efficacy and safety of the ARAKODA ...

CBS News made public all materials tied to a “60 Minutes” interview with former U.S. Vice President and Democratic presidential candidate Kamala Harris that have spurred a $10 billion suit ...

They show – consistent with 60 Minutes' repeated assurances to the public – that the 60 Minutes broadcast was not doctored or deceitful. In reporting the news, journalists regularly edit ...

CBS News will comply with an FCC demand to submit unedited footage of a 60 Minutes interview with former VP Kamala Harris. This follows an FCC inquiry into alleged interview editing that favored ...

60 Degrees Pharmaceuticals, Inc. announced the approval of an Investigational Review Board (IRB) for a Phase II clinical study aimed at evaluating the efficacy and safety of tafenoquine ...

60 Degrees Pharmaceuticals (SXTP) announced the approval of an Investigational Review Board, IRB, sanctioned Phase II clinical study. The study will evaluate the efficacy and safety of the ARAKODA ...